|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.86 EUR | +0.70% |
|
+1.07% | +18.77% |
| Dec. 04 | Grifols achieves self-sufficiency in plasma-derived medicines in Egypt | RE |
| Dec. 03 | European Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | €15.2 | +40.87% | 12 | ||||||
| $782.9 | +5.61% | 26 | ||||||
| A$157 | +28.54% | 16 | ||||||
| ₩2,203,354.67 | +30.22% | 25 | ||||||
| €264.67 | +12.48% | 18 | ||||||
| $180.17 | +3.49% | 29 | ||||||
| HK$99.89 | +29.3% | 25 | ||||||
| $99.62 | +4.41% | 21 | ||||||
| ₩522,000 | +20.55% | 5 | ||||||
| $85.17 | +13.33% | 18 | ||||||
| - | - | - | - | - | ||||
| SEK 367.09 | +11.37% | 11 | ||||||
| $35.37 | +20.06% | 19 | ||||||
| $74 | +3.02% | 11 | ||||||
| $88.48 | +65.97% | 25 | ||||||
| HK$34.74 | +37.77% | 11 | ||||||
| - | - | CN¥50 | +5.98% | 1 | ||||
| $179.74 | +21.31% | 20 | ||||||
| $223 | -8.85% | 10 | ||||||
| Average | 151,560.65 | +19.19% | 17 | ||||||
| Weighted average by Cap. | 299,157.67 | +17.89% | 20 |
- Stock Market
- Equities
- GRF Stock
- Sector Grifols, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
